-
-
-
-
-
-
-
Neuronetics (STIM) Misses Q4 EPS by 1c ; Offers Guidance
-
-
-
-
-
-
-
Neuronetics reports Q3 revenue growth and CEO transition plan
-
-
-
-
-
-
-
Neuronetics (STIM) Misses Q4 EPS by 9c ; Offers Guidance
-
-
-
-
-
-
-
Neuronetics (STIM) Tops Q1 EPS by 2c ; Offers Guidance
-
-
-
-
-
-
-
Neuronetics (STIM) Tops Q4 EPS by 8c
-
-
-
-
-
-
-
William Blair Downgrades Neuronetics (STIM) to Market Perform, Following Earnings
-
-
-
-
-
-
-
Anika Therapeutics Names Board Member Dr. Cheryl Blanchard as Interim CEO
-
1,222,538 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

